ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

XNCR Xencor Inc

18.38
-0.57 (-3.01%)
20 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Xencor Inc XNCR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.57 -3.01% 18.38 10:00:00
Open Price Low Price High Price Close Price Previous Close
18.88 17.945 18.99 18.38 18.95
more quote information »

Recent News

Date Time Source Heading
09/4/202422:01BWXencor Appoints Bart Cornelissen as Chief Financial Officer
12/3/202406:47EDGAR2Form 144 - Report of proposed sale of securities
12/3/202406:45EDGAR2Form 144 - Report of proposed sale of securities
12/3/202406:40EDGAR2Form 144 - Report of proposed sale of securities
12/3/202406:40EDGAR2Form 144 - Report of proposed sale of securities
08/3/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202406:39EDGAR2Form 144 - Report of proposed sale of securities
07/3/202400:32EDGAR2Form 8-K - Current report
06/3/202408:48EDGAR2Form 144 - Report of proposed sale of securities
06/3/202408:34EDGAR2Form 144 - Report of proposed sale of securities
06/3/202408:27EDGAR2Form 144 - Report of proposed sale of securities
29/2/202408:01BWXencor to Present at Upcoming Investor Conferences
28/2/202408:05EDGAR2Form 8-K - Current report
28/2/202408:01BWXencor Reports Fourth Quarter and Full Year 2023 Financial..
21/2/202408:31BWXencor to Host Webcast to Review Fourth Quarter and Full..
17/2/202409:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/2/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202410:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:07EDGAR2Form 144 - Report of proposed sale of securities
04/1/202408:01BWXencor to Present at the 42nd Annual J.P. Morgan Healthcare..
03/1/202400:01BWDane Leone Joins Xencor as Senior Vice President, Corporate..
30/12/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202307:28EDGAR2Form 144 - Report of proposed sale of securities
22/11/202308:01BWXencor to Present at the Piper Sandler 35th Annual..
16/11/202308:02EDGAR2Form 8-K - Current report
08/11/202308:04EDGAR2Form 8-K - Current report
08/11/202308:03EDGAR2Form 8-K - Current report
08/11/202308:01BWXencor Reports Third Quarter 2023 Financial Results
04/11/202303:01BWXencor Presents Preclinical Data from Multiple XmAb®..
01/11/202307:01BWXencor to Host Third Quarter 2023 Financial Results Webcast..
26/10/202323:11EDGAR2Form 8-K - Current report
26/10/202323:01BWXencor Announces Planned Retirement of Chief Financial..
27/9/202323:01BWXencor to Present Multiple Posters at the SITC Annual..
20/9/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202306:31EDGAR2Form 8-K - Current report
20/9/202306:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/9/202306:01BWXencor Appoints Barbara J. Klencke, M.D., to Board of..
04/8/202307:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:02EDGAR2Form 8-K - Current report
04/8/202306:01BWXencor Reports Second Quarter 2023 Financial Results
27/7/202322:01BWXencor to Host Second Quarter 2023 Financial Results Webcast..
03/7/202321:16EDGAR2Form 8-K - Current report
31/5/202308:01BWXencor Presents Clinical Results from Phase 1a Study of..
09/5/202306:01BWXencor Reports First Quarter 2023 Financial Results

Your Recent History

Delayed Upgrade Clock